- Home
- TEM vs RGEN Comparison
TEM vs RGEN Comparison
Compare TEM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEM
- RGEN
- Stock Information
- Founded
- TEM 2015
- RGEN 1981
- Country
- TEM United States
- RGEN United States
- Employees
- TEM N/A
- RGEN N/A
- Industry
- TEM
- RGEN Medical/Dental Instruments
- Sector
- TEM
- RGEN Health Care
- Exchange
- TEM NYSE
- RGEN Nasdaq
- Market Cap
- TEM 9.3B
- RGEN 8.2B
- IPO Year
- TEM 2024
- RGEN N/A
- Fundamental
- Price
- TEM $50.09
- RGEN $145.78
- Analyst Decision
- TEM Strong Buy
- RGEN Buy
- Analyst Count
- TEM 9
- RGEN 10
- Target Price
- TEM $45.25
- RGEN $188.38
- AVG Volume (30 Days)
- TEM 1.2M
- RGEN 815.6K
- Earning Date
- TEM 11-17-2024
- RGEN 10-29-2024
- Dividend Yield
- TEM N/A
- RGEN N/A
- EPS Growth
- TEM N/A
- RGEN N/A
- EPS
- TEM N/A
- RGEN N/A
- Revenue
- TEM $595,570,000.00
- RGEN $602,354,000.00
- Revenue This Year
- TEM $32.58
- RGEN $0.08
- Revenue Next Year
- TEM $32.44
- RGEN $12.97
- P/E Ratio
- TEM N/A
- RGEN N/A
- Revenue Growth
- TEM 85.73
- RGEN N/A
- 52 Week Low
- TEM $22.89
- RGEN $110.45
- 52 Week High
- TEM $77.00
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- TEM N/A
- RGEN 50.39
- Support Level
- TEM N/A
- RGEN $135.88
- Resistance Level
- TEM N/A
- RGEN $150.72
- Average True Range (ATR)
- TEM 0.00
- RGEN 5.37
- MACD
- TEM 0.00
- RGEN -0.37
- Stochastic Oscillator
- TEM 0.00
- RGEN 58.10
About TEM TEMPUS AI INC
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.